<div id="readability-page-1"><article>- Company to host conference call and webcast on May 7, 2026, at 8:00 a.m. ET (8:00 p.m. HKT) SHANGHAI &amp; CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that it will report its first quarter 2026 financial results and provide recent corporate updates on May 7, 2026, before the opening of U.S. equity markets. The announcement will be followed by a conference call and webcast at 8:00 a.m. ET (8:00 p.m. HKT).Conference Call and Webcast InformationThe live webcast can be accessed by visiting the Company's website at http://ir.zailaboratory.com. Participants must register in advance of the conference call.Details are as follows:<ul><li>Registration link for webcast (preferred): https://edge.media-server.com/mmc/p/s7q4ox5h</li><li>Registration link for dial-in: https://register-conf.media-server.com/register/BI802954894429400baf012f775762af29</li></ul>All participants must use the link provided above to complete the online registration process in advance of the conference call. Dial-in details will be in the confirmation email which the participant will receive upon registering. A replay will be available shortly after the call and can be accessed by visiting the Company's website.About Zai LabZai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) is an innovative, research-based, commercial-stage biopharmaceutical company based in China and the United States. We are focused on discovering, developing, and commercializing innovative products that address medical conditions with significant unmet needs in the areas of oncology, immunology, neuroscience, and infectious disease. Our goal is to leverage our competencies and resources to positively impact human health.For additional information about Zai Lab, please visit www.zailaboratory.com or follow us at www.X.com/ZaiLab_Global.<img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA0MjIzODQxMDByMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA0MjIzODQxMDByMQ"/>View source version on businesswire.com: https://www.businesswire.com/news/home/20260422384100/en/<div>For more information, please contact: Investor Relations: Christine Chiou / Cyan Liu +1 (917) 886-6929 / +86 195 3130 8895 christine.chiou1@zailaboratory.com / cyan.liu@zailaboratory.comMedia: Shaun Maccoun / Xiaoyu Chen +1 (857) 270-8854 / +86 185 0015 5011 shaun.maccoun@zailaboratory.com / xiaoyu.chen@zailaboratory.com</div>Source: Zai Lab Limited</article></div>

09688

ZLAB

SBIO

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) will announce its first quarter 2026 financial results and recent corporate updates on May 7, 2026, before U.S. market opening. A conference call and webcast will follow at 8:00 a.m. ET (8:00 p.m. HKT). Participants must register in advance for the call. Zai Lab is a biopharmaceutical company focused on innovative products in oncology, immunology, neuroscience, and infectious diseases.

- Zai Lab Limited will report its first quarter 2026 financial results and provide corporate updates on May 7, 2026.  
- A conference call and webcast will follow the announcement at 8:00 a.m. ET (8:00 p.m. HKT), with registration required in advance.  
- Zai Lab is a biopharmaceutical company focused on developing innovative products for unmet medical needs in oncology, immunology, neuroscience, and infectious diseases.

StockTitan

ZAI LAB

Zai Lab

ALPS Medical Breakthrough

SPDR S&P Biotech

Proshares Ultra Nasdaq Biotech

Ark Genomic Revolution ETF

VanEck Biotech ETF

Health Care Select Sector SPDR

Invesco Nasdaq Biotechnology ETF

First Trust NYSE Arca Biotech Index Fd

VG Health

Direxion S&P Biotech Bull 3X

iShares Biotechnology ETF

Invesco Biotechnology & Genome ETF

Zai Lab to Announce First Quarter 2026 Financial Results and Recent Corporate Updates on May 7, 2026 | ZLAB Stock News